Search Results - "Facchinetti, V"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Perspectives on the development of novel potentially active quinolones against tuberculosis and cancer by Facchinetti, V, Gomes, C R B, de Souza, M V N, Vasconcelos, T R A

    Published in Mini reviews in medicinal chemistry (01-08-2012)
    “…Quinolones and its derivatives comprise an important group of heterocyclic compounds that exhibit a wide range of pharmacological properties such as…”
    Get more information
    Journal Article
  2. 2

    DDX1, DDX21, and DHX36 Helicases Form a Complex with the Adaptor Molecule TRIF to Sense dsRNA in Dendritic Cells by Zhang, Zhiqiang, Kim, Taeil, Bao, Musheng, Facchinetti, Valeria, Jung, Sung Yun, Ghaffari, Amir Ali, Qin, Jun, Cheng, Genhong, Liu, Yong-Jun

    Published in Immunity (Cambridge, Mass.) (24-06-2011)
    “…The innate immune system detects viral infection predominantly by sensing viral nucleic acids. We report the identification of a viral sensor, consisting of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Isolation and characterization of the human A-myb promoter : regulation by NF-Y and Sp1 by FACCHINETTI, V, LOPA, R, SPREAFICO, F, BOLOGNESE, F, MANTOVANI, R, TAVNER, F, WATSON, R, INTRONA, M, GOLAY, J

    Published in Oncogene (10-08-2000)
    “…The A-myb transcription factor shows a restricted tissue distribution and is cell cycle regulated. Furthermore its deregulation has profound effects on the…”
    Get full text
    Journal Article
  5. 5

    CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59 by Golay, Josée, Lazzari, Manuela, Facchinetti, Valeria, Bernasconi, Sergio, Borleri, Gianmaria, Barbui, Tiziano, Rambaldi, Alessandro, Introna, Martino

    Published in Blood (01-12-2001)
    “…Complement-dependent cytotoxicity is thought to be an important mechanism of action of the anti-CD20 monoclonal antibody rituximab. This study investigates the…”
    Get full text
    Journal Article
  6. 6

    Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2 by Golay, J, Manganini, M, Facchinetti, V, Gramigna, R, Broady, R, Borleri, G, Rambaldi, A, Introna, M

    Published in Haematologica (Roma) (01-09-2003)
    “…Department of Immunology and Cell Biology, Istituto Ricerche Farmacologiche Mario Negri, via Eritrea 62, 20157 Milan, Italy. golay@marionegri.it BACKGROUND AND…”
    Get full text
    Journal Article
  7. 7

    Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules by Facchinetti, V, Loffarelli, L, Schreek, S, Oelgeschläger, M, Lüscher, B, Introna, M, Golay, J

    Published in Biochemical journal (15-06-1997)
    “…The A-Myb transcription factor belongs to the Myb family of oncoproteins and is likely to be involved in the regulation of proliferation and/or differentiation…”
    Get full text
    Journal Article
  8. 8

    The A-Myb Transcription Factor in Neoplastic and Normal B Cells by Golay, Josée, Facchinetti, Valeria, Ying, Guoguang, Introna, Martino

    Published in Leukemia & lymphoma (01-07-1997)
    “…The myb family of transcription factors has been strongly implicated in the regulation of cell growth and differentiation in the haematopoietic system. The…”
    Get full text
    Journal Article
  9. 9